Investigation of the absorption, metabolism, excretion, and mass balance of [14C]-pacritinib in healthy subjects: a phase I study

被引:1
|
作者
Al-Fayoumi, Suliman
Amberg, Sherri
Zhou, Huafeng
Millard, Lindsey
Singer, Jack W.
Dean, James P.
机构
关键词
D O I
10.1158/1538-7445.AM2016-CT159
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CT159
引用
收藏
页数:4
相关论文
共 50 条
  • [1] THE MASS BALANCE RECOVERY, ABSORPTION, METABOLISM, AND EXCRETION OF [14C]-ORVEPITANT IN HEALTHY MALE SUBJECTS AFTER ORAL DOSING: RADIOSYNTHESIS OF [14C]-ORVEPITANT
    Carver, David
    Craig, Jo
    Lawrence, Ron
    Pawsey, Steve
    Cousins, Peggy
    Martos, Jose
    Shaw, Iain
    DRUG METABOLISM AND PHARMACOKINETICS, 2024, 55
  • [2] THE MASS BALANCE RECOVERY, ABSORPTION, METABOLISM, AND EXCRETION OF [14C]-ORVEPITANT IN HEALTHY MALE SUBJECTS AFTER ORAL DOSING: CLINICAL CONDUCT & MASS BALANCE
    Shaw, Iain
    Singh, Nand
    Melbourne, Sue
    Cooke, Ray
    Lock, Ruth
    Pawsey, Steve
    DRUG METABOLISM AND PHARMACOKINETICS, 2024, 55
  • [3] The Mass Balance Recovery, Absorption, Metabolism, and Excretion of [14C]Orvepitant in Healthy Male Subjects After Oral Dosing: Radiosynthesis
    Carver, D.
    Cousin, P.
    Martos, J.
    Craig, J.
    Lawrence, R.
    Shaw, I.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2024, 67 (10): : 354 - 354
  • [4] Absorption, Distribution, Metabolism and Excretion of [14C]Dexlansoprazole in Healthy Male Subjects
    Brian Grabowski
    Ronald D. Lee
    Clinical Drug Investigation, 2012, 32 : 319 - 332
  • [5] A Phase I, Open-Label, Mass Balance Study of [14C]-Iberdomide in Healthy Subjects
    Yiming Cheng
    Xiaomin Wang
    Liangang Liu
    Jose Silva
    Michael Thomas
    Yan Li
    European Journal of Drug Metabolism and Pharmacokinetics, 2024, 49 : 355 - 365
  • [6] A Phase I, Open-Label, Mass Balance Study of [14C]-Iberdomide in Healthy Subjects
    Cheng, Yiming
    Wang, Xiaomin
    Liu, Liangang
    Silva, Jose
    Thomas, Michael
    Li, Yan
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2024, 49 (03) : 355 - 365
  • [7] Absorption, metabolism, excretion, and safety of [14C]almonertinib in healthy Chinese subjects
    Zhou, Chen
    Xie, Lijun
    Liu, Wei
    Zhang, Lingling
    Zhou, Sufeng
    Wang, Lu
    Chen, Juan
    Li, Huan
    Zhao, Yuqing
    Zhu, Bei
    Ding, Sijia
    Zhang, Chen
    Shao, Feng
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (10)
  • [8] Absorption, distribution, metabolism, and excretion of [14C]-labeled naloxegol in healthy subjects
    Bui, Khanh
    She, Fahua
    Hutchison, Michael
    Brunnstrom, Asa
    Sostek, Mark
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (10) : 838 - 846
  • [9] Absorption, Distribution, Metabolism and Excretion of [14C]Dexlansoprazole in Healthy Male Subjects
    Grabowski, Brian
    Lee, Ronald D.
    CLINICAL DRUG INVESTIGATION, 2012, 32 (05) : 319 - 332
  • [10] THE MASS BALANCE, RECOVERY, ABSORPTION, METABOLISM, AND EXCRETION OF [14C]-ORVEPITANT IN HEALTHY MALE SUBJECTS AFTER ORAL DOSING: METABOLITE CHARACTERISATION
    Colato, Dimitri
    Bordini, Ellenia
    Cufari, Domenico
    Lock, Ruth
    Pawsey, Steve
    Melbourne, Sue
    Shaw, Iain
    DRUG METABOLISM AND PHARMACOKINETICS, 2024, 55